Health & Biotech
Wellnex says it is ready to get ‘product on Aussie shelves by Xmas’ after deal opens giant new med-cannabis market
Health & Biotech
EZZ Life Science Holdings takes big leaps for future global growth
Health & Biotech
Another breakthrough for Zantrene as Race Oncology significantly expands its addressable market
Health & Biotech
Creso ready to capitalise on potential US reclassification of cannabis
Health & Biotech
Prescient Therapeutics at forefront of overcoming challenges with game-changing CAR-T cell cancer therapies
Health & Biotech
Check Up: Blood clots are a $55bn opportunity and these 2 ASX stocks are vying for a slice
Health & Biotech
Wellnex hits record Q1 revenue as exclusive nationwide Mark Wahlberg, A2 formula launches unveiled
Health & Biotech
Nutritional Growth Solutions reaches new heights with record third quarter revenue
Health & Biotech
ASX Health Stocks: Paradigm soars 19pc after meeting primary endpoint of Phase 2 trial
Health & Biotech
PharmAust doses first patient in Phase 1/2 trial of monepantel treating Motor Neurone Disease
Health & Biotech
ASX Health Stocks: On FDA Monday Mesoblast has lifesaving evidence; Lumos hits a roadblock
Health & Biotech
Weed Week: Greens push hard to legalise cannabis and Cronos has 3% of Aussie GPs on its platform already
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.